Abasic sites in DNA of HeLa cells induced by lucanthone

被引:22
作者
Mendez, F [1 ]
Goldman, JD [1 ]
Bases, RE [1 ]
机构
[1] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Radiat Oncol, Bronx, NY 10467 USA
关键词
D O I
10.1081/CNV-120005914
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Abasic sitesdouble dagger in HeLa cell DNA were increased infrequency by exposing the cells to lucanthone. Cell growth in the presence of lucanthone caused progressive accumulation of abasic sites and loss of cellular DNA. After 2 hr in 8 muM lucanthone, the abundance of abasic sites was 2.4 fold greater than the background of 9.9 +/- 2.0 SE abasic sites/10(6) nucleotides; 80 muM lucanthone in the growth medium increased the level 12.6 +/- 2.5 SE fold and decreased the DNA content in HeLa cells to one-half of the value obtained in untreated cells. The frequency of abasic sites in cellular DNA was determined by the aldehyde reactive probe method, with reference to abasic sites created in plasmid pBR322. The ability of lucanthone to inhibit the normal repair of abasic sites might reflect inhibition of apurinic/apyrimidinic endonuclease (HAP1) by the drug, thereby preventing an early step in the base excision repair pathway. Unrepaired abasic sites prevalent after ionizing radiation are cytotoxic lesions that promote DNA strand breaks. These results suggest a rationale for the joint lethal effects of lucanthone and ionizing radiation in cells and the accelerated tumor regression observed in cancer patients who received the combined therapy.
引用
收藏
页码:983 / 991
页数:9
相关论文
共 28 条
  • [1] Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage
    Arai, K
    Morishita, K
    Shinmura, K
    Kohno, T
    Kim, SR
    Nohmi, T
    Taniwaki, M
    Ohwada, S
    Yokota, J
    [J]. ONCOGENE, 1997, 14 (23) : 2857 - 2861
  • [2] A method for detecting abasic sites in living cells: Age-dependent changes in base excision repair
    Atamna, H
    Cheung, I
    Ames, BN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 686 - 691
  • [3] BASES R, 1970, CANCER RES, V30, P2007
  • [4] DNA INTERCALATING AGENTS AS ADJUVANTS IN RADIATION-THERAPY
    BASES, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 (3-4): : 345 - 346
  • [5] ENHANCED EXCISION REPAIR ACTIVITY IN MAMMALIAN-CELLS AFTER IONIZING-RADIATION
    BASES, R
    FRANKLIN, WA
    MOY, T
    MENDEZ, F
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1992, 62 (04) : 427 - 441
  • [6] Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy
    Bases, RE
    Mendez, F
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (05): : 1133 - 1137
  • [7] BESSHO T, 1993, J BIOL CHEM, V268, P19416
  • [8] Stimulation of topoisomerase II-mediated DNA cleavage by an indazole analogue of lucanthone
    Dassonneville, L
    Bailly, C
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (08) : 1307 - 1312
  • [9] Accelerated regression of brain metastases in patients receiving whole brain radiation and the topoisomerase II inhibitor, lucanthone
    Del Rowe, JD
    Bello, J
    Mitnick, R
    Sood, B
    Filippi, C
    Moran, J
    Freeman, K
    Mendez, F
    Bases, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (01): : 89 - 93
  • [10] DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition
    Fortune, JM
    Velea, L
    Graves, DE
    Utsugi, T
    Yamada, Y
    Osheroff, N
    [J]. BIOCHEMISTRY, 1999, 38 (47) : 15580 - 15586